Related Experiment Video
Updated: Mar 25, 2026

03:40
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
2.0K
Research involving pediatric stem cell donors: A way forward
David Wendler1, Nirali N Shah2, Michael A Pulsipher3
1Department of Bioethics, NIH Clinical Center, Bethesda, MD, USA dwendler@nih.gov.
Clinical Trials (London, England)
|February 25, 2016
Summary
Minor siblings donating stem cells for research require careful ethical consideration. This article proposes using regulatory waivers to ensure proper review without hindering life-saving pediatric research.
Area of Science:
- Pediatric Hematology
- Bioethics
- Clinical Research Regulations
Background:
- Minor siblings are common donors for pediatric hematopoietic stem cell transplantation (HSCT) in research.
- Current regulations may not adequately address the unique ethical considerations of pediatric stem cell donors.
- Treating pediatric donors as research subjects can create regulatory hurdles for essential research.
Purpose of the Study:
- To examine the ethical and regulatory challenges of using pediatric stem cell donors in research.
- To propose a novel approach for reviewing and approving the involvement of pediatric donors in HSCT research.
- To balance the protection of pediatric donors with the advancement of critical medical research.
Main Methods:
- Analysis of existing US federal regulations for pediatric research.
- Exploration of the applicability of regulatory waivers for research involving pediatric stem cell donors.
- Ethical and legal review of the proposed approach.
Main Results:
- Existing regulations, designed for patients, may not be optimal for healthy pediatric donors.
- Regulatory waivers offer a potential mechanism to streamline review processes.
- The proposed approach aims to ensure adequate oversight without impeding research.
Conclusions:
- A nuanced approach is needed to ethically and effectively involve pediatric stem cell donors in research.
- Leveraging regulatory waivers can facilitate necessary HSCT research.
- Balancing donor protection and research advancement is crucial for pediatric medicine.
Related Concept Videos
Adult Stem Cells
34.3K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
34.3K
Stem Cell Culture
6.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Bone Marrow Sampling and Transplants
2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Induced Pluripotent Stem Cells
6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.2K
Induced Pluripotent Stem Cells
28.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.5K

